MAKING GREAT DRUGS BETTER

Home
About
- - - ABOUT RE-VANA
  - - About
    - Learn more about our story and our company aims.
  - - News
    - Keep up-to-date with the latest Re-Vana news, publications and presentations.
  - - Careers
    - See what opportunities our company can offer.
Our Technology
- - - OUR TECHNOLOGY
  - - Our Technology
    - Learn more about our innovative technology.
  - - EyeLief®
    - Find out more about our biodegradable, preformed implant.
  - - OcuLief®
    - Find out more about our biodegradable, in situ forming implant.
Pipeline
The Team
- - - THE TEAM
  - - Management
    - Meet our researchers and management team members.
  - - Board of Directors
    - Meet our Board of Directors.
  - - Advisory Board
    - Meet our Scientific Advisory Board.
Partnerships
Contact

News

Dr Thakur RR Singh – will be holding Ocular Drug Delivery (OcDD) focus group at the Controlled Release Society, New York, USA, July 21-24th 2018.

by Re-Vana Therapeutics | Jul 1, 2018 | News | 0 comments

Dr Thakur RR Singh – will be holding Ocular Drug Delivery (OcDD) focus group at the Controlled Release Society, New York, USA, July 21-24th 2018.